<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT933-15082</title>
	</head>
	<body>
		<main>
			<p>930710 FT  10 JUL 93 / International Company News: Roussel-Uclaf oversubscribed The French tranche of the public share offer for Franco-German pharmaceutical group Roussel-Uclaf was largely oversubscribed, the Paris bourse said. The offer closed on Thursday and Roussel-Uclaf shares will resume trading Monday, AP-DJ reports. The bourse said buyers would get 44.57 per cent of their orders. After the 'clawback' of 584,791 shares from the international tranche, 4,483,398 shares were sold in Paris at FFr563 a share, compared with requests for 10,057,407 shares. The shares had belonged to Rhone-Poulenc, the French state-controlled chemicals and drug group, and represented 35 per cent of Roussel-Uclaf's capital</p>
		</main>
</body></html>
            